BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16963591)

  • 1. Preliminary FMRI evidence of visual system dysfunction in Parkinson's disease patients with visual hallucinations.
    Holroyd S; Wooten GF
    J Neuropsychiatry Clin Neurosci; 2006; 18(3):402-4. PubMed ID: 16963591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations.
    Meppelink AM; de Jong BM; Renken R; Leenders KL; Cornelissen FW; van Laar T
    Brain; 2009 Nov; 132(Pt 11):2980-93. PubMed ID: 19755518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural brain abnormalities in patients with Parkinson's disease with visual hallucinations: a comparative voxel-based analysis.
    Gama RL; Bruin VM; Távora DG; Duran FL; Bittencourt L; Tufik S
    Brain Cogn; 2014 Jun; 87():97-103. PubMed ID: 24732953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral basis of visual hallucinations in Parkinson's disease: structural and functional MRI studies.
    Ibarretxe-Bilbao N; Junque C; Marti MJ; Tolosa E
    J Neurol Sci; 2011 Nov; 310(1-2):79-81. PubMed ID: 21705027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing an aetiological model of visual hallucinations in Parkinson's disease.
    Gallagher DA; Parkkinen L; O'Sullivan SS; Spratt A; Shah A; Davey CC; Bremner FD; Revesz T; Williams DR; Lees AJ; Schrag A
    Brain; 2011 Nov; 134(Pt 11):3299-309. PubMed ID: 21921019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral atrophy in Parkinson's disease patients with visual hallucinations.
    Ramírez-Ruiz B; Martí MJ; Tolosa E; Giménez M; Bargalló N; Valldeoriola F; Junqué C
    Eur J Neurol; 2007 Jul; 14(7):750-6. PubMed ID: 17594330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy.
    Franciotti R; Delli Pizzi S; Perfetti B; Tartaro A; Bonanni L; Thomas A; Weis L; Biundo R; Antonini A; Onofrj M
    Mov Disord; 2015 Aug; 30(9):1237-47. PubMed ID: 26094856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain response to complex visual stimuli in Parkinson's patients with hallucinations: a functional magnetic resonance imaging study.
    Ramírez-Ruiz B; Martí MJ; Tolosa E; Falcón C; Bargalló N; Valldeoriola F; Junqué C
    Mov Disord; 2008 Dec; 23(16):2335-43. PubMed ID: 18785653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.
    Goldman JG; Stebbins GT; Dinh V; Bernard B; Merkitch D; deToledo-Morrell L; Goetz CG
    Brain; 2014 Mar; 137(Pt 3):849-59. PubMed ID: 24480486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson's disease.
    Shin S; Lee JE; Hong JY; Sunwoo MK; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2012 Dec; 83(12):1155-61. PubMed ID: 22933812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease.
    Bronnick K; Emre M; Tekin S; Haugen SB; Aarsland D
    Mov Disord; 2011 Apr; 26(5):824-9. PubMed ID: 21437985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal visual activation in Parkinson's disease patients.
    Cardoso EF; Fregni F; Maia FM; Melo LM; Sato JR; Cruz AC; Bianchi ET; Fernandes DB; Monteiro ML; Barbosa ER; Amaro E
    Mov Disord; 2010 Aug; 25(11):1590-6. PubMed ID: 20623771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Default mode network connectivity patterns associated with visual processing at different stages of Parkinson's disease.
    Rektorova I; Krajcovicova L; Marecek R; Novakova M; Mikl M
    J Alzheimers Dis; 2014; 42 Suppl 3():S217-28. PubMed ID: 25114077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual dysfunction in Parkinson's disease.
    Rodnitzky RL
    Clin Neurosci; 1998; 5(2):102-6. PubMed ID: 10785835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal psychophysical visual perception in Parkinson's disease patients.
    Crevits L
    Acta Neurol Belg; 2003 Jun; 103(2):83-7. PubMed ID: 12892001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations.
    Meppelink AM; de Jong BM; Teune LK; van Laar T
    Mov Disord; 2011 Jan; 26(1):142-7. PubMed ID: 20922809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The physiological basis of visual hallucinations after damage to the primary visual cortex.
    De Haan EH; Nys GM; van Zandvoort MJ; Ramsey NF
    Neuroreport; 2007 Jul; 18(11):1177-80. PubMed ID: 17589322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fiber-specific white matter reductions in Parkinson hallucinations and visual dysfunction.
    Zarkali A; McColgan P; Leyland LA; Lees AJ; Rees G; Weil RS
    Neurology; 2020 Apr; 94(14):e1525-e1538. PubMed ID: 32094242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. I finally see what you see: Parkinson's disease visual hallucinations captured with functional neuroimaging.
    Goetz CG; Vaughan CL; Goldman JG; Stebbins GT
    Mov Disord; 2014 Jan; 29(1):115-7. PubMed ID: 23843193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating visual misperceptions in Parkinson's disease: a novel behavioral paradigm.
    Shine JM; Halliday GH; Carlos M; Naismith SL; Lewis SJ
    Mov Disord; 2012 Apr; 27(4):500-5. PubMed ID: 22488861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.